[HTML][HTML] The coagulopathy, endotheliopathy, and vasculitis of COVID-19
Abstract Background COVID-19-associated coagulopathy (CAC) characterized by the
elevated D-dimer without remarkable changes of other global coagulation markers is …
elevated D-dimer without remarkable changes of other global coagulation markers is …
COVID-19-associated coagulopathy: an exacerbated immunothrombosis response
A Jayarangaiah, PT Kariyanna… - Clinical and Applied …, 2020 - journals.sagepub.com
Since the onset of the global pandemic in early 2020, coronavirus disease 2019 (COVID-19)
has posed a multitude of challenges to health care systems worldwide. In order to combat …
has posed a multitude of challenges to health care systems worldwide. In order to combat …
Coronavirus disease 2019–associated coagulopathy
Patients with the severe form of coronavirus disease 2019 (COVID-19) have been frequently
found to suffer from both arterial and venous thrombotic events due to the perpetuation of a …
found to suffer from both arterial and venous thrombotic events due to the perpetuation of a …
[HTML][HTML] COVID-19-associated coagulopathy
M Franchini, G Marano, M Cruciani, C Mengoli, I Pati… - Diagnosis, 2020 - degruyter.com
Abstract Coronavirus disease 2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently …
[HTML][HTML] Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy
R Cacciola, E Gentilini Cacciola, V Vecchio… - Journal of Thrombosis …, 2022 - Springer
Abstract Introduction Coronavirus 2 (CoV-2) infection or coronavirus disease 2019 (COVID-
19) is frequently associated with microvascular thrombosis. The microthrombosis in COVID …
19) is frequently associated with microvascular thrombosis. The microthrombosis in COVID …
COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation
Abstract COVID-19-associated coagulopathy (CAC) is a feature of COVID-19 that can lead
to various thrombotic complications and death. In this review, we briefly highlight possible …
to various thrombotic complications and death. In this review, we briefly highlight possible …
Coagulation dysfunction: a hallmark in COVID-19
Context.—The coronavirus disease 2019 (COVID-19) is a highly contagious respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
[HTML][HTML] Interrelationship between COVID-19 and coagulopathy: pathophysiological and clinical evidence
B Ragnoli, B Da Re, A Galantino, S Kette… - International Journal of …, 2023 - mdpi.com
Since the first description of COVID-19 infection, among clinical manifestations of the
disease, including fever, dyspnea, cough, and fatigue, it was observed a high incidence of …
disease, including fever, dyspnea, cough, and fatigue, it was observed a high incidence of …
[HTML][HTML] Fundamentals in COVID-19-associated thrombosis: molecular and cellular aspects
The novel coronavirus disease (COVID-19) is associated with a high incidence of
coagulopathy and venous thromboembolism that may contribute to the worsening of the …
coagulopathy and venous thromboembolism that may contribute to the worsening of the …
Coagulopathy in COVID-19: Focus on vascular thrombotic events
W Shi, J Lv, L Lin - Journal of molecular and cellular cardiology, 2020 - Elsevier
SARS-CoV-2 causes a phenotype of pneumonia with diverse manifestation, which is termed
as coronavirus disease 2019 (COVID-19). An impressive high transmission rate allows …
as coronavirus disease 2019 (COVID-19). An impressive high transmission rate allows …